Fatty Liver
Information
- Disease name
- Fatty Liver
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05695118 | Active, not recruiting | N/A | Body Composition and Fatty Liver Disease | February 10, 2023 | December 31, 2024 |
| NCT05855239 | Active, not recruiting | Quantification of Hepatic Steatosis With Different Ultrasound Frequency | June 8, 2023 | December 31, 2024 | |
| NCT04463667 | Active, not recruiting | N/A | Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease | August 25, 2020 | December 31, 2023 |
| NCT06220695 | Active, not recruiting | N/A | A Nutrigenetic Intervention in MASLD | October 19, 2023 | October 18, 2024 |
| NCT03375788 | Active, not recruiting | Phase 2 | Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk | January 17, 2019 | December 1, 2024 |
| NCT00207311 | Completed | Phase 4 | Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus | August 2005 | May 2009 |
| NCT00229255 | Completed | N/A | Relation of Obesity With Frequency of Meals (MST 0557) | March 2005 | June 2009 |
| NCT00244569 | Completed | Phase 3 | Development of a Breath Test for Monitoring Patients With Liver Disease | September 2005 | April 2007 |
| NCT05804422 | Completed | N/A | Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) | February 1, 2023 | December 31, 2023 |
| NCT00266019 | Completed | Phase 2 | Weight Management in Nonalcoholic Steatohepatitis | January 2005 | December 2007 |
| NCT00274183 | Completed | Nonalcoholic Fatty Liver Disease in Taiwanese Children | January 2006 | December 31, 2018 | |
| NCT05792423 | Completed | N/A | Conditionally Increased Output (CIO) Enhanced Ultrasound System | June 30, 2023 | May 31, 2024 |
| NCT00323414 | Completed | Phase 2 | Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver | April 2006 | December 2011 |
| NCT00443079 | Completed | Phase 2 | A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH) | March 2007 | December 2009 |
| NCT05351853 | Completed | N/A | Metabolic Effects of Plant-based Diet | October 1, 2021 | July 30, 2022 |
| NCT00476879 | Completed | N/A | Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content | August 2006 | June 2008 |
| NCT05317260 | Completed | Steatohepatitis in Chronic Hepatitis B | January 1, 2002 | December 31, 2021 | |
| NCT00501592 | Completed | Phase 2 | Study of INT-747 in Patients With Diabetes and Presumed NAFLD | July 2007 | April 2009 |
| NCT05280145 | Completed | N/A | Efficacy of the echOpen Device to Detect Pyelocaliceal Dilation and Hepatic Steatosis | August 21, 2022 | November 17, 2023 |
| NCT05194553 | Completed | Identification and Characterization of NAFLD in Turkey | February 15, 2022 | June 15, 2023 | |
| NCT05015491 | Completed | N/A | Effects of Online App Weight Loss Programs on Liver Health in Obese Adults | August 9, 2021 | September 12, 2022 |
| NCT04853082 | Completed | Early Phase 1 | Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution | February 22, 2021 | October 25, 2021 |
| NCT00585299 | Completed | N/A | Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD | October 2006 | September 2010 |
| NCT00594412 | Completed | N/A | MRI to Measure Liver Fat Content | December 20, 2007 | June 15, 2011 |
| NCT00681408 | Completed | Phase 2/Phase 3 | Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH) | March 2007 | August 2010 |
| NCT04462562 | Completed | N/A | Quantitative US for Evaluation of Hepatic Steatosis in NAFLD | July 3, 2020 | June 29, 2021 |
| NCT04281121 | Completed | N/A | Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver | March 1, 2019 | February 19, 2020 |
| NCT00774579 | Completed | The Effect of Growth Hormone Replacement on Liver Fat | March 2008 | October 2009 | |
| NCT00799578 | Completed | Phase 1/Phase 2 | A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) | October 2008 | January 2010 |
| NCT00815009 | Completed | N/A | Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease | October 2008 | December 2010 |
| NCT04161703 | Completed | N/A | Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver Disease | November 20, 2019 | March 20, 2020 |
| NCT00862433 | Completed | Phase 1 | Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women | October 10, 2014 | May 3, 2022 |
| NCT00885313 | Completed | Phase 1/Phase 2 | Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) | March 2009 | March 2011 |
| NCT00930371 | Completed | N/A | Effect of Diet Composition on Liver Fat and Glucose Metabolism | June 2009 | September 2012 |
| NCT00949403 | Completed | Early Phase 1 | Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease | July 2010 | January 19, 2011 |
| NCT01038102 | Completed | N/A | Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance | February 2009 | April 2010 |
| NCT01100398 | Completed | Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy | January 2007 | May 2010 | |
| NCT01147523 | Completed | Phase 2 | Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease | January 2010 | December 2011 |
| NCT01234714 | Completed | Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications | October 2010 | July 2011 | |
| NCT04022681 | Completed | Long-term Follow Up of Patients in the Birmingham and Lambeth Liver Evaluation Strategies (BALLETS) Study | December 1, 2005 | July 1, 2013 | |
| NCT01284634 | Completed | Phase 2 | Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease | May 3, 2011 | July 13, 2012 |
| NCT04004273 | Completed | N/A | Diabetes, Exercise and Liver Fat (DELIVER) | October 30, 2018 | July 20, 2022 |
| NCT03726827 | Completed | A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations | December 1, 2018 | August 31, 2019 | |
| NCT03656068 | Completed | Phase 2 | An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis | December 4, 2018 | November 25, 2020 |
| NCT01464801 | Completed | N/A | Resveratrol in Patients With Non-alcoholic Fatty Liver Disease | September 2011 | June 2015 |
| NCT03614039 | Completed | N/A | Effect of Probiotic and Smectite Gel on NAFLD | September 15, 2015 | April 20, 2016 |
| NCT01682655 | Completed | Genetic Variant in Apolipoprotein C3 Gene and Fatty Liver in Obese Children | July 2012 | December 2014 | |
| NCT03513523 | Completed | N/A | Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers | April 18, 2018 | August 17, 2020 |
| NCT03508687 | Completed | Phase 1/Phase 2 | Study of Gemcabene in Adults With FPLD | March 13, 2018 | July 31, 2019 |
| NCT01725035 | Completed | Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth | December 2010 | August 10, 2022 | |
| NCT01761318 | Completed | Phase 4 | Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients | November 2013 | March 2016 |
| NCT01766960 | Completed | Phase 1 | Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease | November 2012 | June 2014 |
| NCT01792115 | Completed | Phase 2 | Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E | May 1, 2013 | August 30, 2019 |
| NCT01817491 | Completed | N/A | Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol | March 2013 | December 2014 |
| NCT01876108 | Completed | Phase 2 | The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease | July 2012 | July 2013 |
| NCT01934777 | Completed | Phase 3 | Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis | October 2013 | July 2015 |
| NCT01992809 | Completed | Phase 3 | Omega 3 Supplementation in Fatty Liver | September 2009 | June 2011 |
| NCT02009592 | Completed | N/A | Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients | June 2013 | February 2014 |
| NCT02031913 | Completed | Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD | January 2013 | December 2022 | |
| NCT02102646 | Completed | Phase 4 | MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism | April 2014 | October 2015 |
| NCT00004697 | Completed | N/A | Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition | November 1997 | March 1999 |
| NCT02210715 | Completed | Phase 4 | Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients | March 2015 | January 30, 2023 |
| NCT03374358 | Completed | Phase 4 | Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir | January 10, 2018 | November 30, 2019 |
| NCT02279524 | Completed | Phase 2 | A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH | April 29, 2015 | May 22, 2018 |
| NCT02283710 | Completed | Phase 2 | The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease | May 2013 | May 2014 |
| NCT02289235 | Completed | Early Phase 1 | Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM | May 1, 2019 | February 1, 2020 |
| NCT02347007 | Completed | N/A | Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults | October 2014 | March 2019 |
| NCT02358928 | Completed | N/A | Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome | July 2014 | August 18, 2016 |
| NCT02363309 | Completed | Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD) | March 27, 2015 | November 29, 2018 | |
| NCT03233178 | Completed | Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study | January 2017 | June 2017 | |
| NCT02394353 | Completed | Phase 1 | Impact of Bariatric Surgery on the Evolution of Nonalcoholic Fatty Liver Disease: a Comparative Clinical Trial Between Sleeve Gastrectomy and Gastric Bypass | January 2013 | February 2016 |
| NCT02427087 | Completed | N/A | Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity | January 2013 | December 2014 |
| NCT03204552 | Completed | Tzu Chi Health Study (Diabetes and Cardiometabolic Health Components) | October 15, 2007 | December 2017 | |
| NCT02520609 | Completed | Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease | October 28, 2015 | May 14, 2020 | |
| NCT02565446 | Completed | N/A | Transforming Non-Invasive Liver Disease Detection by MRE: The Hepatogram | September 2015 | November 17, 2022 |
| NCT02660047 | Completed | Phase 4 | Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent | August 2015 | March 9, 2018 |
| NCT02669316 | Completed | Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty Liver | January 2008 | December 2015 | |
| NCT03193177 | Completed | A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases | June 20, 2017 | December 31, 2018 | |
| NCT02670590 | Completed | N/A | NAFLD: Independent Effects of Western Dietary Pattern Profile and Sedentary Life | January 2011 | December 2014 |
| NCT02784925 | Completed | N/A | Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement | June 2016 | July 2016 |
| NCT02860884 | Completed | Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease | August 2014 | October 2015 | |
| NCT02983669 | Completed | N/A | The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease | January 2017 | May 10, 2017 |
| NCT03141008 | Completed | Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet | September 15, 2017 | February 27, 2020 | |
| NCT00013598 | Completed | Phase 2 | Treatment of Nonalcoholic Steatohepatitis With Pioglitazone | March 2001 | March 2004 |
| NCT00063635 | Completed | Phase 3 | Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) | September 2005 | February 2010 |
| NCT05804955 | Completed | Alpha-Glutathione-S-Transferase (AlphaGST) and MARINA Index in Metabolic-Dysfunction-Associated-Steatotic-Liver-Disease (MASLD) | January 2, 2017 | July 1, 2022 | |
| NCT00160407 | Completed | Phase 4 | Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) | October 2003 | December 2006 |
| NCT03480594 | Enrolling by invitation | Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway | October 1, 2018 | December 31, 2024 | |
| NCT05933018 | Enrolling by invitation | N/A | Night Hyperglycemia and Fatty Liver in Type 1 Diabetes | January 15, 2023 | July 15, 2024 |
| NCT04786418 | Not yet recruiting | N/A | Low-Calorie Diet in People With Prediabetes/Metabolic Syndrome | April 2021 | December 2024 |
| NCT06433388 | Not yet recruiting | Perirenal Fats of Chronic Kidney Disease in Patients With Fatty Liver Disease. | June 2024 | July 2025 | |
| NCT05984745 | Not yet recruiting | Phase 2 | Effect of CoQ10 on the Outcome of MAFLD Patients | September 2023 | December 2024 |
| NCT05966025 | Not yet recruiting | Phase 2 | Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD) | December 28, 2023 | December 2025 |
| NCT06456970 | Not yet recruiting | Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes | July 1, 2024 | July 1, 2026 | |
| NCT03025074 | Recruiting | Blood Collection Biorepository for Liver Disease Research | July 2013 | December 2099 | |
| NCT03481829 | Recruiting | Early Tracking of Childhood Health Determinants (ETCHED) Study | April 14, 2022 | December 31, 2041 | |
| NCT03849235 | Recruiting | A Pathophysiological Study of the Postprandial Human Liver (PLS) | March 2, 2019 | January 1, 2025 | |
| NCT03851627 | Recruiting | Phase 4 | Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism | January 25, 2022 | December 2028 |
| NCT04302051 | Recruiting | Assessment of Fatty Liver With Thermo-acoustic Device | November 2, 2023 | December 30, 2025 | |
| NCT04371042 | Recruiting | PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies | September 1, 2019 | December 31, 2035 | |
| NCT04899102 | Recruiting | N/A | Intermittent Fasting for NAFLD in Adults | February 1, 2022 | July 31, 2025 |
| NCT05220956 | Recruiting | N/A | Impact of Time-restricted Feeding in NAFLD | October 1, 2021 | December 1, 2024 |
| NCT05351515 | Recruiting | Prevalence of Non-alcoholic Fatty Liver Disease Among Non-obese Obstructive Sleep Apnea by Using Transient Elastography | April 30, 2022 | January 31, 2025 | |
| NCT05623930 | Recruiting | N/A | Liver Enzymes and Metabolic Risk Factors Response to Laser Acupuncture Versus Cupping Therapy in Fatty Liver | October 12, 2022 | April 1, 2023 |
| NCT05719480 | Recruiting | A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer | November 20, 2022 | December 20, 2025 | |
| NCT05769127 | Recruiting | N/A | Diabetes Prevention and Education | April 26, 2023 | December 31, 2026 |
| NCT05979779 | Recruiting | Phase 2 | Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis | September 5, 2023 | April 2025 |
| NCT06051669 | Recruiting | Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US | September 24, 2023 | March 2025 | |
| NCT06203548 | Recruiting | N/A | Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter | February 1, 2024 | April 30, 2027 |
| NCT06225193 | Recruiting | Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population | June 20, 2023 | June 23, 2024 | |
| NCT06257732 | Recruiting | N/A | Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines | January 5, 2024 | October 15, 2024 |
| NCT06386094 | Recruiting | Cardiac Dysfunction in Patients With Non-alcoholic Fatty Liver Disease | July 15, 2023 | November 15, 2025 | |
| NCT00855907 | Terminated | Fatty Liver in Inflammatory Bowel Disease (IBD) Patients | March 2009 | March 2011 | |
| NCT00576667 | Terminated | Phase 3 | An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes | January 2008 | February 2009 |
| NCT00099723 | Terminated | Phase 1 | The Effect of a Probiotic on Hepatic Steatosis | October 2004 | December 2005 |
| NCT00529204 | Terminated | Phase 2 | Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease | October 2007 | February 2010 |
| NCT00577148 | Terminated | Phase 3 | An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes | February 2008 | February 2009 |
| NCT00742326 | Terminated | Phase 4 | Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections | August 2008 | January 2013 |
| NCT00068094 | Terminated | Phase 1/Phase 2 | The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics | July 2005 | February 2006 |
| NCT00736385 | Terminated | Phase 4 | Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) | April 2009 | December 2012 |
| NCT00694746 | Terminated | Phase 1 | Study of Fish Oil to Reduce ALT Levels in Adolescents | June 2008 | March 2014 |
| NCT01423630 | Terminated | N/A | Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver | August 2011 | January 4, 2022 |
| NCT05039710 | Terminated | Phase 1 | A Study of JNJ-75220795 in Japanese Participants | November 8, 2021 | February 22, 2023 |
| NCT00274495 | Terminated | Phase 4 | Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver | January 2006 | October 2007 |
| NCT00252499 | Terminated | N/A | Insulin Resistance in Non-alcoholic Fatty Liver Disease | October 2005 | August 2010 |
| NCT01289639 | Terminated | N/A | Insulin Resistance in Non-alcoholic Fatty Liver Disease | October 2005 | August 2014 |
| NCT00152815 | Terminated | Phase 2 | Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions | October 2003 | December 2010 |
| NCT02265276 | Unknown status | Phase 3 | A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease | October 2014 | September 2015 |
| NCT02174367 | Unknown status | An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis | November 2012 | July 2021 | |
| NCT02669641 | Unknown status | Phase 4 | Complex Imaging Assessment of Steatosis | January 2016 | December 2016 |
| NCT01720719 | Unknown status | Phase 4 | Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease | May 2013 | December 2016 |
| NCT01694342 | Unknown status | Telomere Parameters in Patients With Nonalcoholic Fatty Liver | September 2012 | ||
| NCT03599882 | Unknown status | Liver Steatosis and Stiffness in HIV | August 1, 2018 | July 31, 2019 | |
| NCT01543646 | Unknown status | Multiparametric MR for Rapid Imaging Assessment of the Liver | March 2011 | September 2012 | |
| NCT01457625 | Unknown status | Clinical Study of Serum Fetuin A Level, Insulin Resistance and Hepatic Fat Content in Dialysis Patients | January 2011 | January 2014 | |
| NCT03737071 | Unknown status | N/A | The Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial Fluxes | November 15, 2018 | November 2022 |
| NCT03972319 | Unknown status | Early Phase 1 | Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study | September 17, 2019 | April 2023 |
| NCT04160949 | Unknown status | A Pilot Study to Explore the Role of Gut Flora in Fatty Liver | March 2, 2020 | July 2023 | |
| NCT04415632 | Unknown status | N/A | Low GI Diet Effects on Non-Alcoholic Fatty Liver Disease | December 10, 2020 | October 2023 |
| NCT04702490 | Unknown status | Phase 2 | Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH | December 15, 2020 | June 2022 |
| NCT02276144 | Unknown status | Metabolic Syndrome and Non-alcoholic Fatty Liver During Pregnancy | November 2014 | December 2021 | |
| NCT03358420 | Unknown status | Inflammation and Steatosis: the Role of Alpha-defensin | December 2017 | July 2018 | |
| NCT04971434 | Unknown status | N/A | Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping | July 11, 2021 | December 1, 2021 |
| NCT00577044 | Unknown status | Non Alcoholic Fatty Liver Disease (NAFLD) in Hong Kong | June 2004 | December 2007 | |
| NCT05125757 | Unknown status | N/A | Lifestyle Modification in Psoriatic Patients With Fatty Liver | September 13, 2021 | March 15, 2022 |
| NCT02391168 | Unknown status | Fatty Liver Disease Collaborative Research in China | July 2015 | December 2020 | |
| NCT05308160 | Unknown status | Phase 3 | A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver Disease | June 28, 2021 | April 30, 2024 |
| NCT00482924 | Unknown status | Observational Study of Early Metabolic and Vascular Changes in Obesity | January 2003 | December 2022 | |
| NCT00471575 | Unknown status | Fatty Liver in Pregnancy | June 2007 | December 2007 | |
| NCT05370053 | Unknown status | N/A | The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology | September 1, 2020 | December 1, 2022 |
| NCT02456766 | Unknown status | Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis | June 2014 | June 2015 | |
| NCT00303537 | Unknown status | Phase 2/Phase 3 | Metformin in Non-Alcoholic Fatty Liver Disease | November 2004 | June 2008 |
| NCT01282892 | Unknown status | Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary Atherosclerosis | February 2009 | December 2010 | |
| NCT02873507 | Withdrawn | N/A | Prediction of Donor Liver Adipose Content by Magnetic Resonance Imaging | May 2018 | December 2018 |
| NCT03914482 | Withdrawn | N/A | Fatty Liver Imaging Project ( FLIP ) Patient Pilot Study | January 1, 2024 | December 30, 2024 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D005234